Anna Maria Schimizzi

Author

Ospedali Riuniti di Ancona

Also Known As

A. M. Schimizzi, A.M. Schimizzi, Anna M. Schimizzi, Anna Maria Schimizzi, Giorgio Saracco

Publications

760

Citations

H-Index

Concepts

All Affiliations

Ospedali Riuniti di Ancona Marche Polytechnic University The University of Texas Health Science Center at San Antonio University of Florence Ospedale Buon Consiglio Fatebenefratelli

About

Anna Maria Schimizzi is an author at Ospedali Riuniti di Ancona specializing in medicine, clinical microbiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	540
2	Microbiology	5	5	521
3	Emergency Medicine	1	1	321
4	Epidemiology	1	1	19
5	Hepatology	1	1	19

Anna Maria Schimizzi

Publications

705

Citations

H-Index

Page 1

	Year	Citations
Epidemiology and Microbiology of Surgical Wound Infections Andrea Giacometti, Oscar Cirioni, Anna Maria Schimizzi, Journal of Clinical Microbiology Surgery PatientsSurgeryBacterial PathogensSurgical Wound InfectionsSurgical Site Infections	2000	321
Interactions between Triazoles and Amphotericin B against <i>Cryptococcus neoformans</i> Francesco Barchiesi, Anna Maria Schimizzi, Francesca Caselli, Antimicrobial Agents and Chemotherapy	2000	77
In Vitro Activity of the New Echinocandin Antifungal, MK-0991, against Common and Uncommon Clinical Isolates of Candida Species Francesco Barchiesi, Anna Maria Schimizzi, Annette W. Fothergill, European Journal of Clinical Microbiology & Infectious Diseases Antifungal AgentAntifungal AgentsMedicineCandida SpeciesNew Echinocandin Antifungal	1999	74
Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis Francesco Barchiesi, Massimo Cogliati, Maria Carmela Esposto, Journal of Infection Pathogenic MicrobiologyPathogenesisPathologyCryptococcus NeoformansPathogen Characterization	2004	69
In Vitro Activity of the New Echinocandin Antifungal, MK-0991, against Common and Uncommon Clinical Isolates of Francesco Barchiesi, Anna Maria Schimizzi, Annette W. Fothergill, European Journal of Clinical Microbiology & Infectious Diseases Antifungal AgentAntifungal AgentsMedicineNew Echinocandin AntifungalAntimicrobial Chemotherapy	1999	43
Interactions of Posaconazole and Flucytosine against<i>Cryptococcus neoformans</i> Francesco Barchiesi, Anna Maria Schimizzi, Laura K. Najvar, Antimicrobial Agents and Chemotherapy	2001	39
Posaconazole and Amphotericin B Combination Therapy against <i>Cryptococcus neoformans</i> Infection Francesco Barchiesi, Elisabetta Spreghini, Anna Maria Schimizzi, Antimicrobial Agents and Chemotherapy	2004	28
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study Salvatore Petta, Marco Marzioni, Pierluigi Russo, The Lancet. Gastroenterology & hepatology HepatologyHepatitis CViral HepatitisProspective Observational StudyAntiviral Therapy	2017	19
Unusual clinical presentation of infection due toFlavimonas oryzihabitans Oscar Cirioni, Maria Teresa Quarta, Anna Maria Schimizzi, European Journal of Clinical Microbiology & Infectious Diseases Clinical InfectionMicrobiologyInfection ControlMedicineClinical Microbiology	1998	14
Point prevalence survey of antibiotic use and healthcare-associated infections in acute care hospitals: a comprehensive report from the Marche Region of Italy Pamela Barbadoro, Jacopo Dolcini, C Fortunato, Journal of Hospital Infection	2023	11

Page 1